Keywords
adenocarcinoma lung - mutations classic EGFR - Gefitinib
Bibliographical Record
Isabela Fernandes Rivelli Cardoso, Gabriela Panini Batagelo, Rodrigo de Oliveira Cavagna,
Josiane Mourão Dias, Amelia Gontijo Velozo de Melo, Carlos Eduardo Baston Silva, Gustavo
Dix Junqueira Pinto, Augusto Perazzolo Antoniazzi, Leticia Ferro Leal, Flavio Augusto
Ferreira da Silva. Impact of gefitinib combined with chemotherapy in lung cancer patients
with classic EGFR mutations: a real-world study at Barretos Cancer Hospital. Brazilian
Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808002
